Trial intelligence / Profile preview

Ambroxol inhalation for sticky sputum in children with lower respiratory tract infection

ChiCTR2100043783Phase 4Recruiting

Sponsor
Beijing Children's Hospital
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of ambroxol in pulmonary infection, sponsored by Beijing Children's Hospital. Primary endpoints: Cough improvement rate and Clinical response rate. Started May 2020; status: recruiting.

02

Drugs

ambroxol
03

Conditions

pulmonary infection

Beyond the preview

Go deeper on ChiCTR2100043783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100043783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call